Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research Units
Projects
Activities
Datasets
Equipment
Prizes
Press / Media
Search by expertise, name or affiliation
PRiZM+: A phase II Platform study for Relapsed and Refractory prImary CNS lymphoma with Zanubrutinib
Boucher, Becky
(Co-Investigator)
Craddock, Charles
(Co-Investigator)
Jackson, Aimee
(Principal Investigator)
Fox, Sonia
(Co-Investigator)
Cancer Clinical Trials Unit
Overview
Project Details
Short title
PRiZM+: A phase II Platform study for Relapsed and Refractory prImary CNS lymphoma with Zanubrutinib
Status
Active
Effective start/end date
1/04/22
→
30/06/26
Funding
BeiGene
View all
View less